In the POETIC (Program for Enhanced Training in Cancer) trial, patients with high Ki-67 had a much higher risk of recurrence at 5 years (19.6%) in comparison with those with low Ki-67 (4.5%) [213]. The gene discussed is MKI67; the disease is cancer.